Literature DB >> 6392355

The clearance of cyclosporine by hemodialysis.

R Venkataramanan, R J Ptachcinski, G J Burckart, S L Yang, T E Starzl, D H Van Theil.   

Abstract

The pharmacokinetics of cyclosporine were studied in five liver transplant patients when they were on and off hemodialysis. There was no significant difference in the blood clearance of cyclosporine between these two periods. Less than 1 per cent of the dose of cyclosporine was recovered in the dialysate. The mean dialysis clearance was less than 1 ml/min. This represents less than 1 per cent of the total blood clearance of cyclosporine. Dosage alterations of cyclosporine during or after hemodialysis do not appear to be necessary.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392355      PMCID: PMC2981080          DOI: 10.1002/j.1552-4604.1984.tb02763.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  14 in total

1.  Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.

Authors:  M Lemaire; J P Tillement
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

2.  Results from a single kidney procurement center.

Authors:  J T Rosenthal; D Denny; T R Hakala
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

3.  Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.

Authors:  B A Reitz; C P Bieber; A A Raney; J L Pennock; S W Jamieson; P E Oyer; E B Stinson
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

Authors:  P R Gwilt; D Perrier
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

5.  Method of preservation is not a determinant of graft outcome in kidneys transplanted by Southeastern Organ Procurement Foundation Institutions.

Authors:  W K Vaughn; G Mendez-Picon; A L Humphries; E K Spees
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

6.  Liver transplantation with use of cyclosporin a and prednisone.

Authors:  T E Starzl; G B Klintmalm; K A Porter; S Iwatsuki; G P Schröter
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

7.  Intravenous cyclosporine kinetics in renal failure.

Authors:  F Follath; M Wenk; S Vozeh; G Thiel; F Brunner; R Loertscher; M Lemaire; K Nussbaumer; W Niederberger; A Wood
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

8.  Artificial kidneys and clearance calculations.

Authors:  T P Gibson; E Matusik; L D Nelson; W A Briggs
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

9.  Cyclosporin A in patients receiving renal allografts from cadaver donors.

Authors:  R Y Calne; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; B D Pentlow; K Rolles
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

10.  Cyclosporin A for the treatment of graft-versus-host disease in man.

Authors:  R L Powles; A J Barrett; H Clink; H E Kay; J Sloane; T J McElwain
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

View more
  6 in total

1.  Treatment of a child with acute cyclosporine overdose.

Authors:  A B Anderson; W Primack
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

Review 2.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

3.  Leflunomide in dialysis patients with rheumatoid arthritis--a pharmacokinetic study.

Authors:  Raoul Bergner; Lena Peters; Verena Schmitt; Christian Löffler
Journal:  Clin Rheumatol       Date:  2012-11-22       Impact factor: 2.980

Review 4.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

Review 6.  Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.

Authors:  V Rodighiero
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.